Related MeSH Hierarchy (9)
Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » HIV Infections » AIDS Dementia Complex
Diseases [C] » Infections [C01] » Communicable Diseases » Sexually Transmitted Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » AIDS Dementia Complex
Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Sexually Transmitted Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » AIDS Dementia Complex
Diseases [C] » Infections [C01] » Sexually Transmitted Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » AIDS Dementia Complex
Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Retroviridae Infections » Lentivirus Infections » HIV Infections » AIDS Dementia Complex
Diseases [C] » Infections [C01] » Virus Diseases » Sexually Transmitted Diseases, Viral » HIV Infections » AIDS Dementia Complex
Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Dementia » AIDS Dementia Complex
Diseases [C] » Immune System Diseases [C20] » Immunologic Deficiency Syndromes » HIV Infections » AIDS Dementia Complex
Psychiatry and Psychology [F] » Mental Disorders [F03] » Neurocognitive Disorders » Dementia » AIDS Dementia Complex
Description
A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40) MeSH
Hierarchy View
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (5)
Phase 1 Indicated Drugs (2)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
